Skip to main content

Table 2 Clinical response to colchicine in FMF patients

From: Familial Mediterranean fever is no longer a rare disease in Japan

Subgroups

Response rate

p

Sure

vs

Probable

91/93 (97.8 %)

74/80 (92.5 %)

0.095

(0.82 ± 0.40)*

 

(0.84 ± 0.54)*

   

MEFV mutations (+)

vs

MEFV mutations (–)

154/162 (95.1 %)

11/11 (100 %)

0.585

M694I (+)

vs

M694I (–)

36/37 (97.3 %)

129/136 (94.9 %)

0.459

E148Q (+)

vs

E148Q (–)

109/115 (94.8 %)

56/58 (96.6 %)

0.461

Rheumatic diseases (+)

vs

Rheumatic diseases (–)

23/23 (100 %)

142/150 (94.7 %)

0.311

  1. *Mean dose of colchicine, mg/day. FMF familial Mediterranean fever
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us